Mrv1652310201623012D 14 15 0 0 0 0 999 V2000型0.7145 -0.4125 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 0.7145 -1.2375 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 1.4289 -1.6500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 1.4289 -2.4750 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 0.7145 -2.8875 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 0.0000 -2.4750 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 0.0000 -1.6500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 0.7145 -3.7125 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 1.4289 -4.1250 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 1.4289 -4.9500 0.0000 C0 0 0 0 0 0 0 0 0 0 0 0 0.7145 -5.3625 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -0.0000 -4.9500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 0.0000 -4.1250 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 0.7145 -6.1875 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 1 2 1 0 0 0 0 2 3 2 0 0 0 0 3 4 1 0 0 0 0 4 5 2 0 0 0 0 5 6 1 0 0 0 0 6 7 2 0 0 0 0 2 7 1 0 0 0 0 5 8 1 0 0 0 0 8 9 2 0 0 0 0 9 10 1 0 0 0 0 10 11 2 0 0 0 0 11 12 1 0 0 0 0 12 13 2 0 0 0 0 8 13 1 0 0 0 0 11 14 1 0 0 0 0 M END >
DB11932 >
drugbank >
CC1 = CC = C (N = C1) C1 = CC = C (C) C = N1 >
InChI = 1 s / C12H12N2 c1-9-3-5-11 (13-7-9) 12-6-4-10 (2) 12-6-4-10 / h3-8H 1-2H3 >
PTRATZCAGVBFIQ-UHFFFAOYSA-N >
C12H12N2 >
184.242 >
184.100048394 >
2 >
26日>
21.308173217097377 >
1 >
0 >
0 >
1 >
5、5“-dimethyl-2 2”关于>
2.43 >
2.983669754 >
-2.27 >
0 >
2 >
0 >
3.7957277554247026 >
25.78 >
56.2188 >
1 >
1 >
9.80 e-01 g / l >
5、5“-dimethyl-2 2”关于>
1 >
DB11932 >
批准;临床实验的>
Abametapir >
5、5 ' -Dimethyl-2 2 '关于环;5、5 ' -Dimethyl-2 2 '联吡啶;Abametapir >
Xeglyze >
Xeglyze $ $ $ $